General Information of Drug (ID: DMSX47Q)

Drug Name
Phenylpyrrolidinone derivative 4 Drug Info
Synonyms PMID27646439-Compound-8
Cross-matching ID
PubChem CID
118373037
TTD Drug ID
DMSX47Q

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
HC-5404 DMKFZW5 Breast cancer 2C60-2C65 Phase 1 [2]
Tricyclic isoxazoloquinazoline derivative 2 DMH4TY1 N. A. N. A. Patented [1]
Tricyclic isoxazoloquinazoline derivative 4 DM8VIM4 N. A. N. A. Patented [1]
Tricyclic isoxazoloquinazoline derivative 3 DML2PWF N. A. N. A. Patented [1]
Phenylpyrrolidinone derivative 3 DMPZKQN N. A. N. A. Patented [1]
Indoline derivative 6 DMU5KWC N. A. N. A. Patented [1]
Tricyclic isoxazoloquinazoline derivative 1 DM6QSND N. A. N. A. Patented [1]
Phenylpyrrolidinone derivative 1 DMPAI5C N. A. N. A. Patented [1]
Phenylpyrrolidinone derivative 5 DMZSTLH N. A. N. A. Patented [1]
Indoline derivative 3 DM20YBJ N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
PRKR-like endoplasmic reticulum kinase (PERK) TT5OU0D E2AK3_HUMAN Inhibitor [1]

References

1 Protein kinase R(PKR)-like endoplasmic reticulum kinase (PERK) inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2017 Jan;27(1):37-48.
2 Clinical pipeline report, company report or official report of HiberCell